85 related articles for article (PubMed ID: 9200653)
1. Automated Insulin Delivery for Hypoglycemia Avoidance and Glucose Counterregulation in Long-Standing Type 1 Diabetes with Hypoglycemia Unawareness.
Flatt AJ; Peleckis AJ; Dalton-Bakes C; Nguyen HL; Ilany S; Matus A; Malone SK; Goel N; Jang S; Weimer J; Lee I; Rickels MR
Diabetes Technol Ther; 2023 May; 25(5):302-314. PubMed ID: 36763336
[No Abstract] [Full Text] [Related]
2. Defective awakening response to nocturnal hypoglycemia in patients with type 1 diabetes mellitus.
Schultes B; Jauch-Chara K; Gais S; Hallschmid M; Reiprich E; Kern W; Oltmanns KM; Peters A; Fehm HL; Born J
PLoS Med; 2007 Feb; 4(2):e69. PubMed ID: 17326710
[TBL] [Abstract][Full Text] [Related]
3. Effects of γ-Aminobutyric Acid A Receptor Activation on Counterregulatory Responses to Subsequent Exercise in Individuals With Type 1 Diabetes.
Hedrington MS; Mikeladze M; Tate DB; Younk LM; Davis I; Davis SN
Diabetes; 2016 Sep; 65(9):2754-9. PubMed ID: 27217489
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between residual insulin production and glucagon response to hypoglycemia in youth with short duration of type 1 diabetes.
Sherr J; Xing D; Ruedy KJ; Beck RW; Kollman C; Buckingham B; White NH; Fox L; Tsalikian E; Weinzimer S; Arbelaez AM; Tamborlane WV;
Diabetes Care; 2013 Jun; 36(6):1470-6. PubMed ID: 23288858
[TBL] [Abstract][Full Text] [Related]
5. Hypoglycemia unawareness and autonomic dysfunction in diabetes: Lessons learned and roles of diabetes technologies.
Lin YK; Fisher SJ; Pop-Busui R
J Diabetes Investig; 2020 Nov; 11(6):1388-1402. PubMed ID: 32403204
[TBL] [Abstract][Full Text] [Related]
6. Mini-review: Glucagon responses in type 1 diabetes - a matter of complexity.
Bisgaard Bengtsen M; Møller N
Physiol Rep; 2021 Aug; 9(16):e15009. PubMed ID: 34405569
[TBL] [Abstract][Full Text] [Related]
7. Philip E. Cryer, MD: Seminal Contributions to the Understanding of Hypoglycemia and Glucose Counterregulation and the Discovery of HAAF (Cryer Syndrome).
Dagogo-Jack S
Diabetes Care; 2015 Dec; 38(12):2193-9. PubMed ID: 26604275
[TBL] [Abstract][Full Text] [Related]
8. Drug-delivery research and much more: interview with Dan Peer.
Peer D
Nanomedicine (Lond); 2023 Apr; 18(8):649-652. PubMed ID: 37199195
[No Abstract] [Full Text] [Related]
9. Protective and risk factors of impaired awareness of hypoglycemia in patients with type 1 diabetes: a cross-sectional analysis of baseline data from the PR-IAH study.
Sakane N; Kato K; Hata S; Nishimura E; Araki R; Kouyama K; Hatao M; Matoba Y; Matsushita Y; Domichi M; Suganuma A; Sakane S; Murata T; Wu FL
Diabetol Metab Syndr; 2023 Apr; 15(1):79. PubMed ID: 37095537
[TBL] [Abstract][Full Text] [Related]
10. Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review.
Verhulst CEM; Fabricius TW; Teerenstra S; Kristensen PL; Tack CJ; McCrimmon RJ; Heller S; Evans ML; Amiel SA; Pedersen-Bjergaard U; de Galan BE;
Diabetologia; 2022 Oct; 65(10):1601-1612. PubMed ID: 35867127
[TBL] [Abstract][Full Text] [Related]
11. Glucagon as a Therapeutic Approach to Severe Hypoglycemia: After 100 Years, Is It Still the Antidote of Insulin?
Porcellati F; Di Mauro S; Mazzieri A; Scamporrino A; Filippello A; De Fano M; Fanelli CG; Purrello F; Malaguarnera R; Piro S
Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572493
[TBL] [Abstract][Full Text] [Related]
12. Prevention and Management of Severe Hypoglycemia and Hypoglycemia Unawareness: Incorporating Sensor Technology.
Lucidi P; Porcellati F; Bolli GB; Fanelli CG
Curr Diab Rep; 2018 Aug; 18(10):83. PubMed ID: 30121746
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular Autonomic Neuropathy and Glucose Variability in Patients With Type 1 Diabetes: Is There an Association?
Nyiraty S; Pesei F; Orosz A; Coluzzi S; Vági OE; Lengyel C; Ábrahám G; Frontoni S; Kempler P; Várkonyi T
Front Endocrinol (Lausanne); 2018; 9():174. PubMed ID: 29725320
[TBL] [Abstract][Full Text] [Related]
14. Roles of catechol neurochemistry in autonomic function testing.
Goldstein DS; Cheshire WP
Clin Auton Res; 2018 Jun; 28(3):273-288. PubMed ID: 29705971
[TBL] [Abstract][Full Text] [Related]
15. Metabolic neuroimaging of the brain in diabetes mellitus and hypoglycaemia.
Cheah YS; Amiel SA
Nat Rev Endocrinol; 2012 Oct; 8(10):588-97. PubMed ID: 22733265
[TBL] [Abstract][Full Text] [Related]
16. Insulin therapy and hypoglycemia.
McCall AL
Endocrinol Metab Clin North Am; 2012 Mar; 41(1):57-87. PubMed ID: 22575407
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine responses to hypoglycemia.
Tesfaye N; Seaquist ER
Ann N Y Acad Sci; 2010 Nov; 1212():12-28. PubMed ID: 21039590
[TBL] [Abstract][Full Text] [Related]
18. Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control.
Adler GK; Bonyhay I; Failing H; Waring E; Dotson S; Freeman R
Diabetes; 2009 Feb; 58(2):360-6. PubMed ID: 19056608
[TBL] [Abstract][Full Text] [Related]
19. Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation.
Fanelli C; Pampanelli S; Lalli C; Del Sindaco P; Ciofetta M; Lepore M; Porcellati F; Bottini P; Di Vincenzo A; Brunetti P; Bolli GB
Diabetes; 1997 Jul; 46(7):1172-81. PubMed ID: 9200653
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
